(Q43460233)

23 November 2017

title

Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study (English)

1 reference

Demosthenes B. Panagiotakos

23 November 2017

0 references

1 reference

4

object named as

Demosthenes Panagiotakos

1 reference

23 November 2017

Peter F Kokkinos

1

1 reference

23 November 2017

Charles Faselis

2

1 reference

23 November 2017

Jonathan Myers

3

1 reference

23 November 2017

Michael Doumas

5

1 reference

23 November 2017

language of work or name

English

0 references

publication date

28 November 2012

1 reference

23 November 2017

1 reference

23 November 2017

volume

381

1 reference

23 November 2017

issue

9864

1 reference

23 November 2017

page(s)

394-399

1 reference

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Physical fitness and all-cause mortality. A prospective study of healthy men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Exercise capacity and the risk of death in women: the St James Women Take Heart Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Exercise and physical activity: clinical outcomes and applications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Exercise capacity and mortality in older men: a 20-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Exercise capacity and mortality in black and white men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Exercise capacity and mortality in hypertensive men with and without additional risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Walking compared with vigorous exercise for the prevention of cardiovascular events in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Exercise capacity and mortality among men referred for exercise testing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Exercise capacity and all-cause mortality in African American and Caucasian men with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Comparison of the ramp versus standard exercise protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Generalized equations for predicting functional capacity from treadmill performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

National sources of vital status information: extent of coverage and possible selectivity in reporting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Exercise capacity and body composition as predictors of mortality among men with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Exercise capacity and body mass as predictors of mortality among male veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Physical activity in statin-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

Risk-adjusted mortality rates as a potential outcome indicator for outpatient quality assessments.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961426-3

7 January 2021

10.1016/S0140-6736(12)61426-3

Identifiers

DOI

1 reference

23 November 2017

1 reference